Quadrant Capital Group LLC Cara Therapeutics, Inc. Transaction History

Quadrant Capital Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$8.88 - $12.77 $8,045 - $11,569	906 New	906 $9,000
Q2 2022 Aug 09, 2022	SELL	$7.45 - $13.84 $178 - $332	-24 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$11.99 - $18.14 $443 - $671	-37 Reduced 60.66%	24 $0
Q3 2021 Nov 12, 2021	BUY	$11.55 - $16.06 $704 - $979	61 New	61 $1,000
Q2 2021 Aug 09, 2021	SELL	$12.38 - $29.19 $160 - $379	-13 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$15.07 - $21.71 $195 - $282	13 New	13 $0
Q2 2020 Aug 13, 2020	SELL	$12.39 - $17.33 $185 - $259	-15 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.12 - $17.78 $136 - $266	15 New	15 $0

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.